<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00762372</url>
  </required_header>
  <id_info>
    <org_study_id>BLM-240-003</org_study_id>
    <nct_id>NCT00762372</nct_id>
  </id_info>
  <brief_title>Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane)</brief_title>
  <official_title>Phase 2/3 Clinical Study With BLM-240 in Adult Surgery Patients That Need General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baxter Healthcare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of this study are to evaluate the efficacy and safety of desflurane (BLM-240) as
      an anesthetic agent and to demonstrate the non-inferiority of desflurane to sevoflurane in
      term of awakening/recovery from anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study evaluates the efficacy and safety of the use of desflurane (BLM-240) (with and
      without nitrous oxide) in maintenance of general anesthesia in adult patients undergoing
      surgical procedures typically performed under general anesthesia in Japan (thoracic,
      abdominal, joints, back, and neck), where analgesics and muscle relaxants are concomitantly
      used. The study is also intended to demonstrate the non-inferiority of desflurane with
      nitrous oxide to sevoflurane with nitrous oxide in time to awakening/recovery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anesthetic effectiveness (presence/absence of body movement, presence/absence of awakening, presence/absence of need for rescue medication, control of BP/heart rate, presence/absence of intraoperative recall)</measure>
    <time_frame>anesthesia maintenance</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to extubation</measure>
    <time_frame>end of anesthesia</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Times to awakening, stating birth date, reaching Aldrete score of 8</measure>
    <time_frame>end of anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in BIS</measure>
    <time_frame>anesthesia maintenance</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for rescue treatment</measure>
    <time_frame>anesthesia maintenance</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in end-tidal and inspired concentrations</measure>
    <time_frame>anesthesia maintenance</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>desflurane (BLM-240) concentrations that maintain anesthesia and patient stability without rescue medication for blood pressure or anesthesia</measure>
    <time_frame>anesthesia maintenance</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">216</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>desflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>desflurane/N2O</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane/N2O</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>desflurane</intervention_name>
    <description>volatile liquid for inhalation</description>
    <arm_group_label>desflurane</arm_group_label>
    <other_name>Suprane</other_name>
    <other_name>BLM-240</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>desflurane/nitrous oxide</intervention_name>
    <description>volatile liquid for inhalation with gas for inhalation</description>
    <arm_group_label>desflurane/N2O</arm_group_label>
    <other_name>Suprane</other_name>
    <other_name>BLM-240</other_name>
    <other_name>N2O</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane/nitrous oxide</intervention_name>
    <description>volatile liquid for inhalation and gas for inhalation</description>
    <arm_group_label>sevoflurane/N2O</arm_group_label>
    <other_name>sevoflurane</other_name>
    <other_name>N2O</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA PS 1-3

          -  age: older than 19 y and younger than 70 y

          -  undergoing surgery of the thorax(thoracotomy, thoracotomy plus laparotomy, endoscopy;
             but excluding cardiovascular),abdomen(laparotomy,endoscopy;but excluding cesarean
             section), joints (including peripheral vessels), back (spine)or neck (neck, throat)

          -  willing to be hospitalized for at least 3 days and 2 nights (from the day before
             surgery to the day after surgery)

          -  having given written consent

        Exclusion Criteria:

          -  need for spinal subarachnoid, epidural or local anesthesia (except local surface or
             infiltration anesthesia for catheter insertion or use of local anesthetic for testing
             before inserting epidural catheter for post-surgical pain)

          -  contraindication for use of nitrous during surgery

          -  anticipated need for postoperative transfer to intensive care unit and receive
             mechanical pulmonary ventilation

          -  BMI of 30 kg/m2 or more

          -  serious hepatic, renal, or circulatory disorder (Grade 3 per Notification 80 by MHW,
             Pharmaceutical Affairs Bureau, Safety Division)

          -  uncontrollable hypertension (SBP 160 mmHg or higher while on antihypertensive therapy)

          -  emergency surgery

          -  history of hypersensitivity to components of sevoflurane, fentanyl, propofol,
             vecuronium or other anesthetic

          -  contraindication to sevoflurane, fentanyl, propofol, or vecuronium

          -  exposure or suspected exposure to inhalational halogenated anesthetic within 3 mo
             prior to consent

          -  known or suspected history or family history of malignant hyperthermia

          -  considered likely to have difficulty in receiving tracheal intubation due to
             conditions such as brachygnathia, micrognathia, bucked teeth, articular rheumatism or
             injury of cervical spine/cervical cord

          -  known or suspected to be pregnant or lactating

          -  participated in a clinical study within 6 mo prior to consent

          -  history of drug dependence

          -  history of epilepsy

          -  otherwise judged by the investigator to be unsuitable for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Junzo Takeda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Medicine, Keio University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kagoshima University Medical and Dental University</name>
      <address>
        <city>Kagoshima</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyoto University</name>
      <address>
        <city>Kyoto</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nagoya University</name>
      <address>
        <city>Nagoya</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Okayama University</name>
      <address>
        <city>Okayama</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka University</name>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapporo Medical University</name>
      <address>
        <city>Sapporo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamamatsu University</name>
      <address>
        <city>Shizuoka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jikei University</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Juntendo University</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keio University</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nippon Medical School</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NTT East Japan Kanto Medical</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokai University</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo University</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo Women's Medical University</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2008</study_first_submitted>
  <study_first_submitted_qc>September 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2008</study_first_posted>
  <last_update_submitted>August 16, 2011</last_update_submitted>
  <last_update_submitted_qc>August 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2011</last_update_posted>
  <responsible_party>
    <name_title>Charles H. McLeskey, MD</name_title>
    <organization>Baxter Healthcare Corporation</organization>
  </responsible_party>
  <keyword>anesthesia</keyword>
  <keyword>desflurane</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 23, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

